CRVLB(p) Agilent BioTek Cytation

This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in Federal Acquisition Requirements (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; price quotations are being requested. This solicitation is being issued as a Request for Quotations (RFQ). See the RFQ Solicitation No.: 75D301-23-Q-76161 to read and understand the requrement, terms and conditions. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-07. Quotes shall be submitted by e-mail to Lekeate Nicole Knox, Contracting Officer, at [email protected] , not later than 4:00 PM EST on April 7, 2023 . Any inquiries regarding this solicitation must be sent to Lekeate Nicole Knox, Contracting Officer, at [email protected]. Questions will be accepted not later than 4:00 PM EST on April 5, 2023 . The Defense Priorities and Allocations System (DPAS) does not apply to this acquisition. Award will be made to the lowest priced technically acceptable offer. Attachments: RFQ Solicitation No.: 75D301-23-Q-76161 Brand-Name Justification